19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
1 in 3 U.S. Parents Won't Get Flu Shots for Their Kids: SurveyKids Much Less Prone to Coronavirus Infection Than Adults: StudyImmune System Clues to Why COVID Is Easier on KidsFDA Warns of Danger From 'Benadryl Challenge,' Asks TikTok to Remove VideosAfter COVID-19 Exposure, When Can Young Athletes Resume Play?Kids Who Need Steroids Face Risk of Diabetes, Other IllsMom-to-Be's Pot Use Linked With Higher Odds for Kids' Mental WoesKids Often Hit Hard by Death of Beloved Pet, Study FindsHolidays Can Be a Fright for Kids With Food AllergiesHow to Help Ensure Your Students Get Enough SleepAs Schools Reopen, Many Students, Staff Live With High-Risk Family MemberBlack Kids at Higher Odds for ADHDProbiotic Might Help Ease Children's EczemaMore Than 1 in 3 U.S. Pediatricians Dismiss Vaccine-Refusing FamiliesDeath From COVID-19 Very Rare for Americans 21 and Under: ReportAre School Lunches a Ticket to Healthy Eating?Fewer Kids May Be Carrying Coronavirus Without Symptoms Than Believed: StudyAre At-Home 'Learning Pods' the Right Fit for Your Family?Kids at 2 Utah Day Cares Easily Spread COVID to FamiliesChildren Use Both Sides of the Brain to Understand LanguagePlaying Football at Young Age Doesn't Slow Concussion Recovery in CollegeYouth Vaping Down, But Still Popular: CDCOver Half a Million U.S. Kids Already Infected With COVID-19Rates of Child Hospitalization Similar Between COVID-19, Flu: StudyFirst Trial of Gene-Targeted Asthma Rx in Kids Shows PromiseKids Can Have Coronavirus And Antibodies at Same Time: StudyKeep School Sports Safe During PandemicCOVID-19 Precautions Extend to Car Seats, Seat BeltsAHA News: How to Keep Kids Active While Learning From Home – and Why That's VitalDoes TV And Computer Time Affect Kids' Math, Reading?Kids, Teens Usually Have Mild COVID-19 Infections, Rarely Fatal Ones: StudyUSDA Extends Free School Meals Program Amid PandemicTime Spent in Nature Boosts Kids' Well-BeingSweet-Tooth Tendencies Change as Kids Get Older: StudyA Guide to Managing Children's Diabetes During COVID-19U.S. COVID Cases Pass 6 Million, With Infections Rising in YouthsArtificial Pancreas Controls Diabetes in Kids 6 and Up, Clinical Trial ShowsAHA News: As the Coronavirus Upends Schools, Experts Say Don't Forget the ArtsOne Pandemic Silver Lining: Fewer Severe Asthma Attacks in KidsPandemic Learning Can Strain Children's EyesObesity in Youth Could Be Big Risk Factor for MSDon't Count on Vitamin D to Ease Childhood AsthmaHow to Keep Your Kids Trim Through QuarantineFlu Shots for Kids Protect Everybody, Study ShowsPlay It Safe With Allergies, Asthma During Pandemic School YearAnorexia Often Stunts Girls' Growth, Study FindsHelp Your Child Cope With Back-to-School JittersHigh Viral Loads Make Kids 'Silent Spreaders' of COVID-19Many Child Abuse Cases May Be Going Unreported During PandemicPharmacists in All U.S. States Can Give Kids Childhood Shots
Questions and AnswersVideosLinksBook Reviews
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting

Probiotic Might Help Ease Children's Eczema

HealthDay News
by By Amy Norton
HealthDay Reporter
Updated: Sep 15th 2020

new article illustration

TUESDAY, Sept. 15, 2020 (HealthDay News) -- Applying a type of "good" bacteria to the skin may relieve children of the itch and discomfort of eczema, a new, small study suggests.

Eczema is a chronic inflammatory condition that causes dry, itchy skin and scaly rashes. It usually starts in early childhood, and commonly occurs along with allergies like hay fever and asthma, according to the American Academy of Allergy, Asthma and Immunology.

There are numerous treatments for eczema, both topical and oral, but not all can be given to young kids.

"So, there's a big need for safe and effective treatments for young children," said study author Dr. Ian Myles. He is a researcher and staff clinician with the U.S. National Institute of Allergy and Infectious Diseases.

For the study, his team tested a topical probiotic against eczema in 20 children as young as 3 years of age. Over four months, 17 of the 20 saw their rashes and itchiness fade by more than 50%.

The children were also able to cut down on topical corticosteroids, a standard treatment for eczema -- but one that can cause side effects like thinning of the skin and stretch marks.

The probiotic therapy is a spray solution containing live Roseomonas mucosa bacteria. Those microbes are normally present on the skin, and past research has found that R. mucosa from people with healthy skin can treat eczema in lab mice.

In contrast, samples of the bacteria from people with eczema either had no effect, or made the skin condition worse.

It all fits with evidence that eczema involves an imbalance in the skin's microbiome. That refers to the vast array of bacteria and other microbes that naturally dwell on the skin and help maintain its health.

The skin, Myles explained, has to repair itself from daily wear-and-tear, and the microbiome assists in that. He said R. mucosa appears to produce oils that aid the skin's repair capacity.

The treatment also reduced staph bacteria on the children's skin, and those microbes can worsen eczema symptoms.

Dr. John Browning, a pediatric dermatologist, said, "I think this is a really interesting study." Browning was not involved in the research.

He said people with eczema often get staph infections and need antibiotic treatment. It's possible R. mucosa could be an alternative, according to Browning, who is based at Children's Hospital of San Antonio and Texas Dermatology and Laser Specialists.

The findings, published online Sept. 9 in the journal Science Translational Medicine, are based on 20 children and teenagers who were given the probiotic therapy for four months. They (or their parents) applied the spray solution twice a week for three months, and then every other day for the final month.

On average, Myles said, the kids' itchiness and rash improved by 60% to 75%, with no significant side effects.

And there were signs it could have lasting benefits. Eight months after the therapy was stopped, the good bacteria were still colonizing the children's skin -- indicating R. mucosa had "moved in," Myles explained.

That, he said, suggests the therapy could be one time only. It would still be possible, though, that whatever caused the bacterial imbalance in the skin could do it again.

Myles said a broader goal is to figure out what those factors are -- with diet, soaps and antibiotics being among the suspects.

Browning is part of another trial testing R. mucosa for treating eczema. But he does not think it is the only bacterium that matters.

"There could be a lot of variability patient to patient in whether this approach would be helpful," Browning said.

Myles agreed, noting that not all study patients responded to the probiotic.

It's unclear when the R. mucosa therapy could become commercially available. The U.S. National Institutes of Health has licensed it to a private company, Forte Biosciences, to further develop.

Myles said the company worked to freeze-dry the probiotic so it can be reconstituted with water, then sprayed on. That will make it shelf-stable.

"We anticipate this being something you can pick up at the pharmacy," he said.

More information

The American Academy of Allergy, Asthma and Immunology has more on eczema.